| Symbol | Company | Weighting |
|---|---|---|
| KRRO | KORRO BIO | 3.52% |
| ARWR | ARROWHEAD PHARMACEUTICALS INC | 2.69% |
| EXAS | EXACT SCIENCES CORP | 2.45% |
| OCS | OCULIS HOLDING AG | 2.32% |
| RVMD | REVOLUTION MEDICINES INC | 2.28% |
| AXSM | AXSOME THERAPEUTICS INC. | 2.11% |
| DNLI | DENALI THERAPEUTICS INC. | 1.99% |
| EWTX | EDGEWISE THERAPEUTICS | 1.99% |
| FULC | FULCRUM THERAPEUTICS, INC. | 1.98% |
| SNDX | SYNDAX PHARMACEUTICALS, INC. | 1.96% |
| SPRY | ARS PHARMACEUTICALS | 1.95% |
| MRK | MERCK & CO. NEW | 1.90% |
| RVTY | REVVITY INC | 1.88% |
| BMY | BRISTOL MYERS SQUIBB CO | 1.87% |
| ALKS | ALKERMES INC | 1.87% |
| EYPT | EYEPOINT INC | 1.87% |
| NEO | NEOGENOMICS INC | 1.87% |
| IONS | IONIS PHARMACEUTICALS INC | 1.86% |
| ICLR | ICON PLC | 1.80% |
| TSHA | TAYSHA GENE THERAPIES I | 1.75% |
| PCVX | VAXCYTE INC | 1.75% |
| GEHC | GE HEALTHCARE TECHNOLOGIES INC | 1.74% |
| MDT | MEDTRONIC PLC | 1.72% |
| TNDM | TANDEM DIABETES CARE INC | 1.71% |
| BRKR | BRUKER CORP | 1.70% |
| ZTS | ZOETIS INC | 1.67% |
| ALC | ALCON INC | 1.67% |
| AZN | ASTRAZENECA PLC-ADR | 1.64% |
| ELV | ELEVANCE HEALTH INC | 1.63% |
| ARQT | ARCUTIS BIOTHERAPEUTICS | 1.62% |
| TMO | THERMO FISHER SCIENTIFIC INC | 1.62% |
| XENE | XENON PHARMACEUTICALS | 1.61% |
| IDYA | IDEAYA BIOSCIENCES, INC | 1.61% |
| AVTX | AVALO THERAPEUTICS INC | 1.60% |
| HCA | HCA HOLDINGS INC | 1.60% |
| WAT | WATERS CORP | 1.57% |
| RGEN | REPLIGEN CORP | 1.57% |
| SYK | STRYKER CORP | 1.57% |
| DHR | DANAHER CORP | 1.55% |
| MCK | MCKESSON CORP | 1.55% |
| THC | TENET HEALTHCARE CORP | 1.53% |
| DYN | DYNE THERAPEUTICS, INC. | 1.52% |
| ABBV | ABBVIE INC | 1.48% |
| VCEL | VERICEL CORP | 1.45% |
| TVTX | TRAVERE THERAPEUTICS INC | 1.45% |
| SNY | SANOFI- AVENTIS- ADR | 1.44% |
| BSX | BOSTON SCIENTIFIC | 1.43% |
| ISRG | INTUITIVE SURGICAL INC | 1.41% |
| LLY | ELI LILLY CORP | 1.40% |
| IRON | DISC MEDICINE INC | 1.37% |
| ABT | ABBOTT LABORATORIES | 1.36% |
| UNH | UNITEDHEALTH GROUP INC | 1.36% |
| URGN | UROGEN PHARMA LTD. | 1.32% |
| HUM | HUMANA INC | 1.30% |
| SLNO | SOLENO THERAPEUTICS INC | 1.24% |
| PODD | INSULET CORP | 1.21% |
| PRQR | PROQR THERAPEUTICS NV | 1.20% |
| RARE | ULTRAGENYX PHARMACEUTICAL INC | 1.17% |
| JANX | JANUX THERAPEUTICS INC | 0.75% |
Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or call 800.820.0888.
Investing involves risk, including the possible loss of principal.
Guggenheim Investments represents the following affiliated investment management businesses of Guggenheim Partners, LLC: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Wealth Solutions, LLC, Guggenheim Partners Europe Limited, Guggenheim Partners Japan Limited, GS GAMMA Advisors, LLC, and Guggenheim Private Investments, LLC. Securities offered through Guggenheim Funds Distributors, LLC.
© 2026 Guggenheim Investments. All Rights Reserved.
Research our firm with FINRA Broker Check.
• Not FDIC Insured • No Bank Guarantee • May Lose Value
This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.